These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 3923849

  • 41. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 10; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 44. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep 04; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract] [Full Text] [Related]

  • 45. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union.
    Hurie MB, Gennis MA, Hernandez LV, Dindzans VJ, Davis JP.
    JAMA; 1998 Sep 04; 273(12):954-6. PubMed ID: 7884955
    [Abstract] [Full Text] [Related]

  • 46. Measles, mumps, and rubella vaccines.
    Wharton M, Cochi SL, Williams WW.
    Infect Dis Clin North Am; 1990 Mar 04; 4(1):47-73. PubMed ID: 2407778
    [Abstract] [Full Text] [Related]

  • 47. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 04; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 48. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 04; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 49. A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile.
    Borgoño JM, Greiber R, Solari G, Concha F, Carrillo B, Hilleman MR.
    Clin Pediatr (Phila); 1973 Mar 04; 12(3):170-2. PubMed ID: 4701464
    [No Abstract] [Full Text] [Related]

  • 50. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G.
    Drugs Today (Barc); 2006 May 04; 42(5):321-9. PubMed ID: 16801995
    [Abstract] [Full Text] [Related]

  • 51. [1st results with a combined live vaccine against measles, mumps, and rubella].
    Stehr K, Epp C, Spiess H.
    Monatsschr Kinderheilkd (1902); 1975 May 04; 123(5):410-2. PubMed ID: 1219453
    [No Abstract] [Full Text] [Related]

  • 52. MMR vaccine: a new initiative.
    Miller C.
    Practitioner; 1989 Jan 04; 233(1461):63-4, 66. PubMed ID: 2798287
    [No Abstract] [Full Text] [Related]

  • 53. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468
    [Abstract] [Full Text] [Related]

  • 54. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Apr 06; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 55. [Vaccination against measles, mumps and German measles. II. Socio-economic analysis].
    Bjerregaard P, Pedersen KM, Kamper-Jørgensen F, Koch C, Pedersen FK, Wagner AL, Zoffmann H.
    Ugeskr Laeger; 1985 Sep 16; 147(38):3017-22. PubMed ID: 4071750
    [No Abstract] [Full Text] [Related]

  • 56. MMR and MMRV vaccines.
    Kowalzik F, Faber J, Knuf M.
    Vaccine; 2018 Aug 28; 36(36):5402-5407. PubMed ID: 28757060
    [Abstract] [Full Text] [Related]

  • 57. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA, Nasibov MN, Jakovleva NV.
    Bull World Health Organ; 1970 Aug 28; 42(2):283-9. PubMed ID: 5310140
    [Abstract] [Full Text] [Related]

  • 58. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?
    Cameron NA.
    Vaccine; 2012 Sep 07; 30 Suppl 3():C58-60. PubMed ID: 22939023
    [Abstract] [Full Text] [Related]

  • 59. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV, Iuminova NV.
    Vopr Virusol; 2004 Sep 07; 49(3):8-11. PubMed ID: 15188648
    [Abstract] [Full Text] [Related]

  • 60. [Evaluation of a trivalent combined vaccine against measles, parotiditis and rubella].
    Randall AG, Leonard JM.
    Salud Publica Mex; 1971 Sep 07; 13(3):313-7. PubMed ID: 5164661
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.